CAROL M BALDWIN BREAST CANCER RESEARCH FUND INC (EIN 113342286) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

JEANETTE ZIROGIANNIS

Phone

6313174404

Tax Period

2024-01-01 to 2024-12-31

CAROL M BALDWIN BREAST CANCER RESEARCH FUND INC, founded in 1996, is a small nonprofit in the Medical Research sector that reported $239K in total revenue in fiscal year 2024. Revenue surged 164% from the prior year, signaling strong growth momentum. Expenses of $593K exceeded revenue, resulting in a 148% operating deficit.

Mission

THE PURPOSE OF THE FUND IS TO SUPPORT NEW AND ESTABLISHED RESEARCHERS AT ACADEMIC INSTITUTIONS WHO ARE INVESTIGATING THE CAUSES, PREVENTION AND TREATMENT OF BREAST CANCERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $80,381

Program Service Revenue $0

Investment Income $0

Other Revenue $158,992

TOTAL REVENUE $239,373

Expense Breakdown

Grants Paid $571,548

Salaries & Benefits $12,466

Fundraising Expenses $0

Program Expenses $574,802

Other Expenses $9,222

TOTAL EXPENSES $593,236

Year-over-Year Comparison

	2024	2023	Change
Revenue	$239,373	$90,528	+1.6%
Expenses	$593,236	$118,169	+4.0%
Net Income	$-353,863	$-27,641	+11.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRIAN O'HEA	TRUSTEE	3.00	Director	$0	$0	$0
JEANETTE ZIROGIANNIS	VICE PRESIDENT	3.00	Officer Director	$0	$0	$0
BARBARA CONROY	SECRETARY	3.00	Officer Director	$0	$0	$0
WILLIAM BALDWIN	PRESIDENT	3.00	Officer Director	$0	$0	$0
ELLEN BURKE	TREASURER	3.00	Officer Director	$0	$0	$0
DANIEL BALDWIN	TRUSTEE	1.00	Director	$0	$0	$0
RANDY SASSO	TRUSTEE	1.00	Director	$0	$0	$0
JANE BALDWIN-SALLO	EXECUTIVE DIRECTOR	3.00	Officer Director	$0	$0	$0
D'ASIA BALDWIN	TRUSTEE	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$239,373	$593,236	$286,714	$-353,863
2023	$90,528	$118,169	$732,400	$-27,641
2022	$839,701	$236,981	$877,068	$602,720
2021	$53,241	$123,223	$62,512	$-69,982
2020	$63,551	$81,352	$121,432	$-17,801
2019	$306,419	$240,449	$184,933	$65,970
2018	$299,053	$365,281	$68,963	$-66,228

CAROL M BALDWIN BREAST CANCER RESEARCH FUND INC